Kanishka Das

Contributing Author

Recent Articles by Kanishka Das

10 hours	Will Korlym Continue to Drive Corcept's Top Line in 2026? PFE CORT Zacks
Nov-28	Can NTLA's In Vivo Pipeline Drive Long-Term Growth Amid Rivalry? CRSP NTLA BEAM REGN Zacks
Nov-27	IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? PBYI ABBV IRWD Zacks
Nov-26	Will Soft Gardasil Demand Continue to Dampen Merck's Top Line? MRK AZN SNY Zacks
Nov-21	Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3? ABBV IRWD AZN Zacks
Nov-21	NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock? CRSP NTLA BEAM REGN Zacks
Nov-17	MRK to Buy Cidara for $9.2B: Focus on Buyout Spree Heading Into 2026 CDTX MRK NVO PFE Zacks
Nov-14	Can NTLA Stock Bounce Back in 2026 After Recent Pipeline Setbacks? CRSP NTLA BEAM REGN Zacks
Nov-13	IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock? ABBV IRWD AZN Zacks
Nov-10	Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3? SMMT MRNA MRK Zacks
Oct-27	Is Halozyme Stock a Portfolio Must-Have Ahead of Q3 Earnings? HALO JNJ Zacks
Oct-24	Merck's Non-Oncology Drugs Q3 Performance: What to Expect UTHR MRK JNJ Zacks
Oct-23	Will Higher Royalties From Partners Fuel HALO's Growth in H2 2025? HALO JNJ Zacks
Oct-20	Can NTLA's In Vivo Pipeline Aid Long-Term Growth Amid Competition? CRSP NTLA BEAM REGN Zacks
Oct-17	Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings? MRK AZN SNY Zacks
Oct-16	Halozyme Rallies Almost 40% YTD: How Should You Play the Stock? HALO JNJ Zacks
Oct-14	Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings? TVTX MIRM GSK Zacks
Oct-10	Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings? MRK BMY AZN Zacks
Oct-03	MRK Stock Up Nearly 14% So Far This Week: What's Driving It? LLY MRK PFE AZN Zacks
Oct-02	Can Galafold Drive Amicus' Growth Through the Rest of 2025? FOLD TEVA SNY Zacks
Oct-01	Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym? CORT MRK Zacks
Sep-30	Can Auvelity Drive Axsome's Growth Through the Rest of 2025? AXSM ACAD JAZZ Zacks
Sep-29	Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? RIGL LLY RDY SNY Zacks
Sep-25	RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? FOLD RIGL SNY Zacks
Sep-18	Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? RIGL RDY SNY Zacks
Sep-11	Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? RIGL RDY SNY Zacks
Sep-09	Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds? LLY MRK PFE JNJ Zacks
Sep-03	MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline MRK AZN SNY REGN Zacks
Sep-02	Can Korlym Drive Corcept's Growth Through the Rest of 2025? CORT MRK Zacks
Aug-29	Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy? CRSP NTLA BEAM VRTX Zacks
Aug-28	Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line? MRK AZN SNY Zacks
Aug-22	AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth ABBV INCY LLY PFE Zacks
Aug-21	CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock CRSP NTLA BEAM VRTX Zacks
Aug-19	Can Keytruda Sustain Merck's Growth Through the Rest of 2025? SMMT MRNA MRK Zacks
Jul-30	Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value? MRK PFE BMY Zacks
Jul-14	MRK's Buyout Spree to Broaden Product Portfolio: Can it Aid Growth? LLY MRK SNY Zacks
Jul-09	Merck Faces Multiple Challenges: Will It Steer Through Successfully? LLY MRK PFE JNJ Zacks
Jul-03	MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE UTHR MRK JNJ Zacks
Jun-26	Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE? MRK BMY AZN Zacks

Kanishka Das

Recent Articles by Kanishka Das

Upgrade your FINVIZ experience